Webinar

Understanding the differences between FLT3-ITD and -TKD mutations in AML: Implications for clinical practice

Sunday, November 16, 2025

17:00 (Europe/London)

Add to Calender

Agenda

  • 2025-11-16 17:00 UTC Gail J. Roboz

    Welcome and introductions

  • 2025-11-16 17:05 UTC Jorge Sierra

    FLT3 mutations in AML: Types, prevalence, and clinical significance

  • 2025-11-16 17:15 UTC Jorge Cortes

    Comparing treatment options for patients with FLT3-ITD and 
    -TKD mutations

  • 2025-11-16 17:35 UTC Gail J. Roboz

    Implications for clinical practice: Managing AML with FLT3-ITD and -TKD mutations

  • 2025-11-16 17:50 UTC Gail J. Roboz

    Closing remarks

Learning objectives

After attending this webinar, learners will be able to:

  • Describe novel therapeutic targets in GvHD and explain the mechanisms of action for new agents.
  • Recall the latest data for new agents in development for GvHD and describe the rationale for selecting such treatments based on treatment- and patient-related factors.
  • Explain how quality of life can be impacted in patients with GvHD and how this can be better managed in clinical practice.

Our speakers

Jorge Cortes

Georgia Cancer Center
Augusta, US

Gail J. Roboz

Weill Cornell Medicine
New York, US

Jorge Sierra

Hospital de la Santa Creu i Sant Pau
Barcelona, ES

About SES

Delivering streamlined independent medical education to enhance clinical practice. SES hubs allow time-stretched healthcare professionals to easily access curated scientific, medical, and clinical information that expedites their learning and empowers their treatment decisions. Informed by patients, curated by world leaders, and endorsed by expert societies, our hubs support healthcare professionals worldwide with up-to-date, accessible, and impactful educational content.

Visit SES

About the AML Hub

The AML Hub is an open-access online resource, dedicated to providing balanced, credible, and up-to-date medical education in AML. Our aim is to enhance knowledge in AML through the multichannel dissemination of global advances related to its classification, diagnosis, treatment, and management. The AML Hub shares new data, evidence-based articles, therapy approvals, expert opinions, and international congress coverage with treatment teams and researchers around the world.

Visit the AML Hub

Registration form

Registration is free.

Required fields

Thank you!

You have successfully registered for the webinar.

Please check your email for further information on how to attend.

Add to Calendar